Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
B cell zone reticular cell microenvironments shape CXCL13 gradient formation.
Cosgrove J, Novkovic M, Albrecht S, Pikor NB, Zhou Z, Onder L, Mörbe U, Cupovic J, Miller H, Alden K, Thuery A, O'Toole P, Pinter R, Jarrett S, Taylor E, Venetz D, Heller M, Uguccioni M, Legler DF, Lacey CJ, Coatesworth A, Polak WG, Cupedo T, Manoury B, Thelen M, Stein JV, Wolf M, Leake MC, Timmis J, Ludewig B, Coles MC. Cosgrove J, et al. Among authors: lacey cj. Nat Commun. 2020 Jul 22;11(1):3677. doi: 10.1038/s41467-020-17135-2. Nat Commun. 2020. PMID: 32699279 Free PMC article.
Characterization of a new Leishmania major strain for use in a controlled human infection model.
Ashwin H, Sadlova J, Vojtkova B, Becvar T, Lypaczewski P, Schwartz E, Greensted E, Van Bocxlaer K, Pasin M, Lipinski KS, Parkash V, Matlashewski G, Layton AM, Lacey CJ, Jaffe CL, Volf P, Kaye PM. Ashwin H, et al. Among authors: lacey cj. Nat Commun. 2021 Jan 11;12(1):215. doi: 10.1038/s41467-020-20569-3. Nat Commun. 2021. PMID: 33431825 Free PMC article.
A clinical study to optimise a sand fly biting protocol for use in a controlled human infection model of cutaneous leishmaniasis (the FLYBITE study).
Parkash V, Ashwin H, Sadlova J, Vojtkova B, Jones G, Martin N, Greensted E, Allgar V, Kamhawi S, Valenzuela JG, Layton AM, Jaffe CL, Volf P, Kaye PM, Lacey CJN. Parkash V, et al. Among authors: lacey cjn. Wellcome Open Res. 2021 Jun 30;6:168. doi: 10.12688/wellcomeopenres.16870.1. eCollection 2021. Wellcome Open Res. 2021. PMID: 34693027 Free PMC article.
Overcoming roadblocks in the development of vaccines for leishmaniasis.
Kaye PM, Mohan S, Mantel C, Malhame M, Revill P, Le Rutte E, Parkash V, Layton AM, Lacey CJN, Malvolti S. Kaye PM, et al. Among authors: lacey cjn. Expert Rev Vaccines. 2021 Nov;20(11):1419-1430. doi: 10.1080/14760584.2021.1990043. Epub 2021 Nov 2. Expert Rev Vaccines. 2021. PMID: 34727814 Free PMC article. Review.
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan.
Younis BM, Osman M, Khalil EAG, Santoro F, Furini S, Wiggins R, Keding A, Carraro M, Musa AEA, Abdarahaman MAA, Mandefield L, Bland M, Aebischer T, Gabe R, Layton AM, Lacey CJN, Kaye PM, Musa AM. Younis BM, et al. Mol Ther. 2021 Jul 7;29(7):2366-2377. doi: 10.1016/j.ymthe.2021.03.020. Epub 2021 Mar 27. Mol Ther. 2021. PMID: 33781913 Free PMC article. Clinical Trial.
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH.
Osman M, Mistry A, Keding A, Gabe R, Cook E, Forrester S, Wiggins R, Di Marco S, Colloca S, Siani L, Cortese R, Smith DF, Aebischer T, Kaye PM, Lacey CJ. Osman M, et al. Among authors: lacey cj. PLoS Negl Trop Dis. 2017 May 12;11(5):e0005527. doi: 10.1371/journal.pntd.0005527. eCollection 2017 May. PLoS Negl Trop Dis. 2017. PMID: 28498840 Free PMC article. Clinical Trial.
160 results